Aspen Aerogels sold back to the market after rising nicely since yesterday.
Sells at $19.43 and $19.91, buys were yesterday at €17.03 and last week at $19.25.
Q2 results are coming today, and if there are any comments referring to weakening EV demand, things could get volatile. Otherwise, a strongly growing result is expected based on previous comments.
An interesting stock in the long term, but risks are currently significantly elevated, especially regarding market comments. Might have to put together a thread opening for this 
HIMS position filled back up at $16.26 from the opening dip. Good, strong Q2 result, but not quite enough for the market 
or then the focus is too much on GLP-1 drugs, which don’t have a major significance for the big picture.
Thanks again @karhulalainen for the good summary 
https://keskustelut.inderes.fi/t/hims-hers-kolmessa-vuodessa-kannattavaksi/25734/339?u=kettunen